These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 29532110)

  • 1. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
    Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
    Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoengineering of CHO Cells to Improve Product Quality.
    Wang Q; Yin B; Chung CY; Betenbaugh MJ
    Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody glycoengineering strategies in mammalian cells.
    Wang Q; Chung CY; Chough S; Betenbaugh MJ
    Biotechnol Bioeng; 2018 Jun; 115(6):1378-1393. PubMed ID: 29457629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoengineering Chinese hamster ovary cells: a short history.
    Donini R; Haslam SM; Kontoravdi C
    Biochem Soc Trans; 2021 Apr; 49(2):915-931. PubMed ID: 33704400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic engineering of CHO cells to prepare glycoproteins.
    Wang Q; Betenbaugh MJ
    Emerg Top Life Sci; 2018 Oct; 2(3):433-442. PubMed ID: 33525787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHOGlycoNET: Comprehensive glycosylation reaction network for CHO cells.
    Kotidis P; Donini R; Arnsdorf J; Hansen AH; Voldborg BGR; Chiang AWT; Haslam SM; Betenbaugh M; Jimenez Del Val I; Lewis NE; Krambeck F; Kontoravdi C
    Metab Eng; 2023 Mar; 76():87-96. PubMed ID: 36610518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.
    Zhong X; Ma W; Meade CL; Tam AS; Llewellyn E; Cornell R; Cote K; Scarcelli JJ; Marshall JK; Tzvetkova B; Figueroa B; DiNino D; Sievers A; Lee C; Guo J; Mahan E; Francis C; Lam K; D'Antona AM; Zollner R; Zhu HL; Kriz R; Somers W; Lin L
    Biotechnol Prog; 2019 Jan; 35(1):e2724. PubMed ID: 30299005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation control technologies for recombinant therapeutic proteins.
    Gupta SK; Shukla P
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Producing Biologics with Defined N-Glycosylation in Plants.
    Esqueda A; Chen Q
    Methods Mol Biol; 2023; 2597():235-250. PubMed ID: 36374425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoengineering in CHO Cells: Advances in Systems Biology.
    Tejwani V; Andersen MR; Nam JH; Sharfstein ST
    Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
    Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
    Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
    Wang Q; Aliyu L; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
    Methods Mol Biol; 2024; 2810():249-271. PubMed ID: 38926284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity.
    North SJ; Huang HH; Sundaram S; Jang-Lee J; Etienne AT; Trollope A; Chalabi S; Dell A; Stanley P; Haslam SM
    J Biol Chem; 2010 Feb; 285(8):5759-75. PubMed ID: 19951948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
    Wang Q; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
    Methods Mol Biol; 2018; 1850():237-257. PubMed ID: 30242691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
    Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
    Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Highly Sialylated Recombinant Glycoproteins Using Ricinus communis Agglutinin-I-Resistant CHO Glycosylation Mutants.
    Goh JS; Chan KF; Song Z
    Methods Mol Biol; 2015; 1321():323-33. PubMed ID: 26082232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
    Wong NS; Yap MG; Wang DI
    Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A; Shanmugam D; Gadgil M
    Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells.
    Barlan K; Bhide GP; White DR; Lake MR; Lu C; Rieder SE; Fan L; Hsieh CL
    SLAS Discov; 2024 Jan; 29(1):52-58. PubMed ID: 37844762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel system for glycosylation engineering by natural and artificial miRNAs.
    Klingler F; Naumann L; Schlossbauer P; Dreyer L; Burkhart M; Handrick R; Junker HD; Hesse F; Neusüß C; Otte K
    Metab Eng; 2023 May; 77():53-63. PubMed ID: 36906118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.